The TRPC6 channel activator hyperforin induces the release of zinc and calcium from mitochondria

Journal of Neurochemistry

Volumn 112, Issue 1, 2010, Pages 204-213

  Tu, Peng ^a,b,c   Gibon, Julien ^a,b,c   Bouron, Alexandre ^a,b,c  

^a CNRS   (France)

^b CEA GRENOBLE   (France)

^c UNIV GRENOBLE ALPES   (France)

Author keywords

Brain; Calcium; Cortex; Mice; Zinc

Indexed keywords

CALCIUM; CARBONYL CYANIDE CHLOROPHENYLHYDRAZONE; DIACYLGLYCEROL; FLUO 4; FLUORESCENT DYE; FLUOZIN 3; HYPERFORIN; RUTHENIUM RED; TRANSIENT RECEPTOR POTENTIAL CHANNEL 1; TRANSIENT RECEPTOR POTENTIAL CHANNEL 3; TRANSIENT RECEPTOR POTENTIAL CHANNEL 4; TRANSIENT RECEPTOR POTENTIAL CHANNEL 5; TRANSIENT RECEPTOR POTENTIAL CHANNEL 6; TRANSIENT RECEPTOR POTENTIAL CHANNEL 7; UNCLASSIFIED DRUG; ZINC;

ANIMAL CELL; ARTICLE; BRAIN CELL; BRAIN MITOCHONDRION; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CELL ORGANELLE; CENTRAL NERVOUS SYSTEM; EMBRYO; MITOCHONDRIAL MEMBRANE POTENTIAL; MOUSE; NONHUMAN; PRIORITY JOURNAL;

HYPERICUM PERFORATUM; MUS;

EID: 71649092032     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2009.06446.x     Document Type: Article

References (58)

1. Aizenman E., Stout A. K., Hartnett K. A., Dineley K. E., McLaughlin B. Reynolds I. J. (2000) Induction of neuronal apoptosis by thiol oxidation: putative role of intracellular zinc release. J. Neurochem. 75, 1878 1888.
2. 2+. J. Biol. Chem. 260, 2719 2727.
3. Berg T. O., Stromhaug P. E., Berg T. Seglen P. O. (1994) Separation of lysosomes and autophagosomes by means of glycyl-phenylalanine-naphthylamide, a lysosome-disrupting cathepsin-C substrate. Eur. J. Biochem. 221, 595 602.
4. 2+ stores is developmentally regulated in embryonic cortical neurons from mice. Brain Res. Dev. Brain Res. 159, 64 71.
5. Bowman E. J., Siebers A. Altendorf K. (1988) Bafilomycins: a class of inhibitors of membrane ATPases from microorganisms, animal cells, and plant cells. Proc. Natl Acad. Sci. USA 85, 7972 7976.
6. Camacho M., Machado J. D., Alvarez J. Borges R. (2008) Intravesicular calcium release mediates the motion and exocytosis of secretory organelles: a study with adrenal chromaffin cells. J. Biol. Chem. 283, 22383 22389.
7. Caporale T., Ciavardelli D., Di Ilio C., Lanuti P., Drago D. Sensi S. L. (2009) Ratiometric-pericam-mt, a novel tool to evaluate intramitochondrial zinc. Exp. Neurol. 218, 228 234.
8. Chatterjee S. S., Bhattacharya S. K., Wonnemann M., Singer A. Muller W. E. (1998) Hyperforin as a possible antidepressant component of hypericum extracts. Life Sci. 63, 499 510.
9. Chatterjee S., Filippov V., Lishko P., Maximyuk O., Noldner M. Krishtal O. (1999) Hyperforin attenuates various ionic conductance mechanisms in the isolated hippocampal neurons of rat. Life Sci. 65, 2395 2405.
10. Chinopoulos C., Starkov A. A. Fiskum G. (2003) Cyclosporin A-insensitive permeability transition in brain mitochondria: inhibition by 2-aminoethoxydiphenyl borate. J. Biol. Chem. 278, 27382 27389.
11. Demaurex N., Poburko D. Frieden M. (2009) Regulation of plasma membrane calcium fluxes by mitochondria. Biochim. Biophys. Acta 1787, 1383 1394.
12. Devinney M. J. 2nd., Reynolds I. J. Dineley K. E. (2005) Simultaneous detection of intracellular free calcium and zinc using fura-2FF and FluoZin-3. Cell Calcium 37, 225 232.
13. Dittmer P. J., Miranda J. G., Gorski J. A. Palmer A. E. (2009) Genetically encoded sensors to elucidate spatial distribution of cellular zinc. J. Biol. Chem. 284, 16289 16297.
14. Drose S. Altendorf K. (1997) Bafilomycins and concanamycins as inhibitors of V-ATPases and P-ATPases. J. Exp. Biol. 200, 1 8.
15. Eckert G. P., Keller J. H., Jourdan C., Karas M., Volmer D. A., Schubert-Zsilavecz M. Muller W. E. (2004) Hyperforin modifies neuronal membrane properties in vivo. Neurosci. Lett. 367, 139 143.
16. 2+ current in cerebellar Purkinje neurons. Pflugers Arch. 440, 427 434.
17. Froestl B., Steiner B. Muller W. E. (2003) Enhancement of proteolytic processing of the beta-amyloid precursor protein by hyperforin. Biochem. Pharmacol. 66, 2177 2184.
18. Gee K. R., Brown K. A., Chen W. N., Bishop-Stewart J., Gray D. Johnson I. (2000) Chemical and physiological characterization of fluo-4 Ca(2+)-indicator dyes. Cell Calcium 27, 97 106.
19. Gee K. R., Zhou Z. L., Ton-That D., Sensi S. L. Weiss J. H. (2002) Measuring zinc in living cells. A new generation of sensitive and selective fluorescent probes. Cell Calcium 31, 245 251.
20. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260, 3440 3450.
21. Gunter T. E. Sheu S. S. (2009) Characteristics and possible functions of mitochondrial Ca(2+) transport mechanisms. Biochim. Biophys. Acta 1787, 1291 1308.
22. Haase H., Hebel S., Engelhardt G. Rink L. (2009) Zinc ions cause the thimerosal-induced signal of fluorescent calcium probes in lymphocytes. Cell Calcium 45, 185 191.
23. 2+ uptake in apoptosis. Cell Calcium 40, 553 560.
24. 2+ release. Cell Calcium 19, 157 165.
25. 2+]. J. Cell Biol. 140, 325 334.
26. Hwang J. J., Lee S. J., Kim T. Y., Cho J. H. Koh J. Y. (2008) Zinc and 4-hydroxy-2-nonenal mediate lysosomal membrane permeabilization induced by H2O2 in cultured hippocampal neurons. J. Neurosci. 28, 3114 3122.
27. Ichas F., Jouaville L. S. Mazat J. P. (1997) Mitochondria are excitable organelles capable of generating and conveying electrical and calcium signals. Cell 89, 1145 1153.
28. Kay A. R. (2004) Detecting and minimizing zinc contamination in physiological solutions. BMC Physiol. 4, 4.
29. Kroemer G., Galluzzi L. Brenner C. (2007) Mitochondrial membrane permeabilization in cell death. Physiol. Rev. 87, 99 163. (Pubitemid 46209992)
30. Kroncke K. D. (2007) Cellular stress and intracellular zinc dyshomeostasis. Arch. Biochem. Biophys. 463, 183 187.
31. Kumar V., Mdzinarishvili A., Kiewert C., Abbruscato T., Bickel U., van der Schyf C. J. Klein J. (2006) NMDA receptor-antagonistic properties of hyperforin, a constituent of St. John's Wort. J. Pharmacol. Sci. 102, 47 54.
32. Leuner K., Kazanski V., Muller M., Essin K., Henke B., Gollasch M., Harteneck C. Muller W. E. (2007) Hyperforin-a key constituent of St. John's wort specifically activates TRPC6 channels. FASEB J. 21, 4101 4111.
33. Lloyd-Evans E., Morgan A. J., He X., Smith D. A., Elliot-Smith E., Sillence D. J., Churchill G. C., Schuchman E. H., Galione A. Platt F. M. (2008) Niemann-Pick disease type C1 is a sphingosine storage disease that causes deregulation of lysosomal calcium. Nat. Med. 14, 1247 1255.
34. Malaiyandi L. M., Vergun O., Dineley K. E. Reynolds I. J. (2005) Direct visualization of mitochondrial zinc accumulation reveals uniporter-dependent and-independent transport mechanisms. J. Neurochem. 93, 1242 1250.
35. 2+ measurements in living cells. Cell Calcium 28, 225 231.
36. Martin J. L., Stork C. J. Li Y. V. (2006) Determining zinc with commonly used calcium and zinc fluorescent indicators, a question on calcium signals. Cell Calcium 40, 393 402.
37. 2+ store in the boutons of hippocampal pyramidal cells. Neuropharmacology 52, 126 135.
38. Mennini T. Gobbi M. (2004) The antidepressant mechanism of Hypericum perforatum. Life Sci. 75, 1021 1027.
39. Muller W. E. (2003) Current St John's wort research from mode of action to clinical efficacy. Pharmacol. Res. 47, 101 109.
40. Muller M., Essin K., Hill K. et al. (2008) Specific TRPC6 channel activation, a novel approach to stimulate keratinocyte differentiation. J. Biol. Chem. 283, 33942 33954.
41. Nathan P. (1999) The experimental and clinical pharmacology of St John's Wort (Hypericum perforatum L.). Mol. Psychiatry 4, 333 338.
42. Nowak G., Szewczyk B. Pilc A. (2005) Zinc and depression. An update. Pharmacol. Rep. 57, 713 718.
43. O'Rourke B. (2007) Mitochondrial ion channels. Annu. Rev. Physiol. 69, 19 49.
44. Palmiter R. D., Cole T. B., Quaife C. J. Findley S. D. (1996) ZnT-3, a putative transporter of zinc into synaptic vesicles. Proc. Natl Acad. Sci. USA 93, 14934 14939.
45. Paoletti P., Vergnano A. M., Barbour B. Casado M. (2009) Zinc at glutamatergic synapses. Neuroscience 158, 126 136.
46. Rousselet E., Richaud P., Douki T., Chantegrel J. G., Favier A., Bouron A. Moulis J. M. (2008) A zinc-resistant human epithelial cell line is impaired in cadmium and manganese import. Toxicol. Appl. Pharmacol. 230, 312 319.
47. Roz N. Rehavi M. (2003) Hyperforin inhibits vesicular uptake of monoamines by dissipating pH gradient across synaptic vesicle membrane. Life Sci. 73, 461 470.
48. Sensi S. L., Ton-That D. Weiss J. H. (2002) Mitochondrial sequestration and Ca(2+)-dependent release of cytosolic Zn(2+) loads in cortical neurons. Neurobiol. Dis. 10, 100 108.
49. 2+ pools. Proc. Natl Acad. Sci. USA 100, 6157 6162.
50. Singaravelu K. Deitmer J. W. (2006) Calcium mobilization by nicotinic acid adenine dinucleotide phosphate (NAADP) in rat astrocytes. Cell Calcium 39, 143 153.
51. Srinivas S. P., Ong A., Goon L. Bonanno J. A. (2002) Lysosomal Ca(2+) stores in bovine corneal endothelium. Invest. Ophthalmol. Vis. Sci. 43, 2341 2350.
52. Szewczyk B., Poleszak E., Sowa-Kucma M. et al. (2008) Antidepressant activity of zinc and magnesium in view of the current hypotheses of antidepressant action. Pharmacol. Rep. 60, 588 589.
53. Treiber K., Singer A., Henke B. Muller W. E. (2005) Hyperforin activates nonselective cation channels (NSCCs). Br. J. Pharmacol. 145, 75 83.
54. Tu P., Brandolin G. Bouron A. (2009a) The anti-inflammatory agent flufenamic acid depresses store-operated channels by altering mitochondrial calcium homeostasis. Neuropharmacology 56, 1010 1016.
55. Tu P., Kunert-Keil C., Lucke S., Brinkmeier H. Bouron A. (2009b) Diacylglycerol analogues activate second messenger-operated calcium channels exhibiting TRPC-like properties in cortical neurons. J. Neurochem. 108, 126 138.
56. Waggoner A. S. (1979) The use of cyanine dyes for the determination of membrane potentials in cells, organelles, and vesicles. Methods Enzymol. 55, 689 695.
57. West A. K., Hidalgo J., Eddins D., Levin E. D. Aschner M. (2008) Metallothionein in the central nervous system: roles in protection, regeneration and cognition. Neurotoxicology 29, 488 502.
58. Zanoli P. (2004) Role of hyperforin in the pharmacological activities of St. John's Wort. CNS Drug Rev. 10, 203 218.